NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2763172)

Published in Cell Cycle on November 29, 2008

Authors

Kathleen A Wilson1, David F Stern

Author Affiliations

1: Department of Pathology and Graduate Program in Genetics, Yale University School of Medicine, New Haven, Connecticut 06510, USA. kathleen.a.wilson@yale.edu

Articles citing this

53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat Cell Biol (2010) 2.88

A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biol (2010) 1.90

Rad17 plays a central role in establishment of the interaction between TopBP1 and the Rad9-Hus1-Rad1 complex at stalled replication forks. Mol Biol Cell (2010) 1.10

Epigenetic regulation of genomic integrity. Chromosoma (2012) 0.93

Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY) (2016) 0.88

NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res (2011) 0.85

A novel MCPH1 isoform complements the defective chromosome condensation of human MCPH1-deficient cells. PLoS One (2012) 0.81

Image-based quantitative determination of DNA damage signal reveals a threshold for G2 checkpoint activation in response to ionizing radiation. Genome Integr (2010) 0.80

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget (2014) 0.78

{Delta}Np73{beta} puts the brakes on DNA repair. Genes Dev (2010) 0.77

SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression. Sci Rep (2017) 0.75

Bora downregulation results in radioresistance by promoting repair of double strand breaks. PLoS One (2015) 0.75

ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis. Proteomes (2014) 0.75

The molecular mechanism of G2M cell cycle arrest induced by AFB1 in the jejunum. Oncotarget (2016) 0.75

Articles cited by this

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (2003) 20.13

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11

Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21

A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J (1997) 15.10

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93

The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science (1988) 11.90

BRCA1 protein products ... Functional motifs... Nat Genet (1996) 11.50

RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell (2007) 9.25

RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell (2007) 8.71

A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67

MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell (2005) 8.39

Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28

Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science (2007) 7.61

Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell (2003) 7.48

BRCA1 mutations in primary breast and ovarian carcinomas. Science (1994) 6.81

MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature (2003) 6.81

Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science (2007) 6.77

Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature (2004) 6.72

RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science (2007) 6.70

The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62

Requirement of the MRN complex for ATM activation by DNA damage. EMBO J (2003) 6.23

MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell (2006) 6.09

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev (2000) 5.90

Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science (2007) 5.88

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A (2000) 5.64

53BP1, a mediator of the DNA damage checkpoint. Science (2002) 5.00

Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev (1996) 4.98

Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci U S A (2007) 4.75

Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science (1999) 4.61

Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science (2004) 4.58

MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature (2003) 4.56

p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol (2003) 4.36

Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J Cell Biol (2005) 3.69

Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci U S A (1994) 3.30

Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J (2004) 3.20

Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res (2000) 3.06

MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature (2003) 3.00

Recombinant ATM protein complements the cellular A-T phenotype. Oncogene (1997) 2.95

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell (2003) 2.90

Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol Cell (2007) 2.88

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet (2001) 2.82

Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol (2004) 2.67

Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat Cell Biol (2000) 2.66

Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control. J Biol Chem (2003) 2.00

Chk2 activation and phosphorylation-dependent oligomerization. Mol Cell Biol (2002) 1.88

53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res (2003) 1.87

53BP1, an activator of ATM in response to DNA damage. DNA Repair (Amst) (2004) 1.84

The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J Biol Chem (2003) 1.84

A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J (2003) 1.82

MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres. Genes Dev (2006) 1.81

MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. J Biol Chem (2007) 1.55

DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40

Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. J Cell Biol (2008) 1.38

NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors. FASEB J (2003) 1.37

NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J Biol Chem (2002) 1.37

NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage. J Biol Chem (2003) 1.34

ATM activation by ionizing radiation requires BRCA1-associated BAAT1. J Biol Chem (2006) 1.27

Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res (2006) 1.19

DNA damage regulates Chk2 association with chromatin. J Biol Chem (2005) 1.11

53BP1 is associated with replication protein A and is required for RPA2 hyperphosphorylation following DNA damage. Oncogene (2005) 0.99

Structural basis for phosphorylation-dependent signaling in the DNA-damage response. Biochem Cell Biol (2005) 0.93

Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland. Oncogene (2004) 0.80

Establishment of a cell-free system to study the activation of Chk2. Methods Mol Biol (2004) 0.77

Articles by these authors

Global analysis of protein phosphorylation in yeast. Nature (2005) 7.46

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00

Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal (2010) 2.95

Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol (2005) 2.95

Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci U S A (2003) 2.38

Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint. Mol Cell (2002) 2.30

Genotype-selective combination therapies for melanoma identified by high-throughput drug screening. Cancer Discov (2012) 1.97

Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J Biol Chem (2004) 1.89

Chk2 activation and phosphorylation-dependent oligomerization. Mol Cell Biol (2002) 1.88

Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem (2002) 1.44

Rad53 phosphorylation site clusters are important for Rad53 regulation and signaling. Mol Cell Biol (2003) 1.42

Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Mol Cancer Res (2011) 1.38

NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors. FASEB J (2003) 1.37

NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J Biol Chem (2002) 1.37

Regulation of CHK2 by DNA-dependent protein kinase. J Biol Chem (2005) 1.29

ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci U S A (2004) 1.29

Interaction of chromatin-associated Plk1 and Mcm7. J Biol Chem (2005) 1.21

FHA domain-mediated DNA checkpoint regulation of Rad53. Cell Cycle (2003) 1.19

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer. Cancer Invest (2005) 1.14

DNA damage regulates Chk2 association with chromatin. J Biol Chem (2005) 1.11

Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Cell Cycle (2005) 1.10

ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res (2008) 1.06

Activation of the checkpoint kinase Rad53 by the phosphatidyl inositol kinase-like kinase Mec1. J Biol Chem (2005) 1.03

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. Cancer Res (2013) 0.99

A Ddc2-Rad53 fusion protein can bypass the requirements for RAD9 and MRC1 in Rad53 activation. Mol Biol Cell (2004) 0.95

Centrosomal Chk2 in DNA damage responses and cell cycle progression. Cell Cycle (2010) 0.95

Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates. Cancer Res (2002) 0.94

Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domain. Nucleic Acids Res (2012) 0.93

Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol (2006) 0.88

The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2. Cell Cycle (2005) 0.86

NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res (2011) 0.85

MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell Melanoma Res (2013) 0.84

Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. Mol Cancer Res (2010) 0.84

Gene expression profiling of ErbB receptor and ligand-dependent transcription. Oncogene (2004) 0.83

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. PLoS One (2013) 0.83

Neuregulin-regulated gene expression in mammary carcinoma cells. Exp Cell Res (2005) 0.81

Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer. Genes Chromosomes Cancer (2008) 0.81

Regulation of the Rad53 protein kinase in signal amplification by oligomer assembly and disassembly. Cell Cycle (2008) 0.81

Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B. J Clin Oncol (2008) 0.79

Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway. Breast Cancer Res (2014) 0.78

EGFs and ERBBs--brief history and prospects. Semin Cell Dev Biol (2010) 0.77

Establishment of a cell-free system to study the activation of Chk2. Methods Mol Biol (2004) 0.77

Production of antibodies that recognize specific tyrosine-phosphorylated peptides. Curr Protoc Cell Biol (2002) 0.76

Production of antibodies that recognize specific tyrosine-phosphorylated peptides. Curr Protoc Immunol (2002) 0.75

In situ detection of specific DNA double strand breaks using rolling circle amplification. Cell Cycle (2005) 0.75